Skip to main content
. 2016 Oct 25;1(3):122–126. doi: 10.1136/svn-2016-000025

Table 1.

Baseline characteristics of patients with and without stroke-associated pneumonia

Pneumonia group Non-pneumonia group p Value
Age, median (IQR), year 70.0 (61.0, 78.0) 64.0 (53.0, 73.0) <0.001*
Sex 0.205
 Male, n, % 134 (55.8) 800 (60.2)
 Female, n, % 106 (44.2) 529 (39.8)
Hypertension, n, % 141 (58.8) 764 (57.5) 0.715
Diabetes mellitus, n, % 71 (29.6) 371 (27.9) 0.597
Hyperlipaemia, n, % 16 (38.1) 142 (10.7) 0.057
History of stroke or TIA, n, % 42 (17.5) 169 (12.7) 0.046*
Valvular heart disease, n, % 2 (0.8) 7 (0.5) 0.563
Coronary heart disease, n,% 24 (10.0) 58 (4.4) <0.001*
Atrial fibrillation, n, % 72 (30.0) 109 (8.2) <0.001*
Congestive heart failure, n, % 3 (1.3) 1 (<0.1) <0.001*
COPD, n, % 15 (6.3) 16 (1.2) <0.001*
History of pneumonia, n,% 17 (7.1) 50 (3.8) 0.019*
Current smoking, n, % 33 (13.8) 148 (11.1) 0.243
Excess alcohol consumption, n, % 25 (10.4) 156 (11.7) 0.555
Found down at onset, n, % 42 (17.5) 80 (6.0) <0.001*
Dyaphasia, n, % 130 (9.8) 272 (20.5) <0.001*
NIHSS, median (IQR) score 9.5 (5, 14.0) 3.0 (1.0, 7.0) <0.001*
GCS, median (IQR) score 14.0 (11.0, 15.0) 15.0 (14.0,15.0) <0.001*
OCSP <0.001*
 Lacunar infarction, n, % 7 (2.9) 66 (4.9)
 Total anterior circulation infarct, n, % 39 (16.3) 61 (4.6)
 Partial anterior circulation infarct, n, % 165 (68.8) 939 (70.7)
 Posterior circulation infarct, n, % 29 (12.1) 263 (19.8)
Glu, median (IQR) mmol/L 6.73 (5.20, 8.60) 5.64 (4.87, 7.13) <0.001*
WCC, median (IQR) 1012/L 8.34 (6.55, 10.71) 6.69 (5.44, 8.22) <0.001*

*p<0.05.

COPD, chronic obstructive pulmonary disease; GCS, Glasgow Coma Scale; NIHSS, National Institutes of Health Stroke Scale; OCSP, Oxfordshire Community Stroke Project; TIA, transient ischaemic attack; WCC, white cell count.